Advarra, the market leader in regulatory reviews and a leading provider of clinical research technology, today announced the ...

Generative artificial intelligence (AI) has absolutely exploded onto the scene. It's become a top strategic priority in the ...

In this video interview, Umesh Chaudhari, executive medical director and global program head of the C5 programs at Regeneron, ...

Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients – – Gemini could potentially ...

Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure ...

LabConnect, a leading global provider of central laboratory services today announced plans to form a strategic collaboration ...

The platform’s architecture allows it to handle everything from small single-site pilot trials to complex multi-phase ...

Elutia (ELUT) announced the publication of clinical and preclinical data supporting the clinical utility of a biologic ...

Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients – – Gemini could potentially ...

Clinical trial participants now expect clinical tools to match the usability of the digital tools they use every day.

Exero Medical has completed the enrolment phase for a clinical trial to evaluate the xBar system in monitoring the ...

A majority of cancer drugs approved in the US during 2019-2022 had “clinical trial uncertainties,” research suggests.